Below are selected publications from 2012; please check here to cite the use of e-Pharmacophores
- • Guasch, L.; Sala, E.; Ojeda, M.J.; Valls, C.; Bladé, C., "Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts," PLoS ONE, 2012, 7(9), e44972. doi:10.1371/journal.pone.0044972
- • Guasch, L.; Ojeda, M.J.; González-Abuín, N.; Sala, E.; Cereto-Massagué, A., "Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assay," PLoS ONE, 2012, 7(9), e44971. doi:10.1371/journal.pone.0044971
- • Singh, Kh.D.; Kirubakaran, P.; Nagarajan, S.; Sakkiah, S.; Muthusamy, K.; Velmurgan, D.; Jeyakanthan, J., "Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease," J. Mol. Model., 2012, 18(1), 39-51
- • Nagamani, S.; Kesavan, C.; Muthusamy, K., "E-Pharmacophore mapping and docking studies on Vitamin D receptor (VDR)," Bioinformation, 2012, 8(15), 705-10
- • Singh, D.V.; Godbole, M.M.; Misra, K., "A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors," J. Mol. Model., 2012, 19(1), 227-238
- ö indicates papers (co)authored by Schrödinger scientist(s).